Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Advance Purchase Agreement

Business Energy and Industrial Strategy

This public procurement record has 1 release in its history.

Award

20 Oct 2021 at 16:33

Award Notice
Summary of the contracting process

The procurement process involves the Business Energy and Industrial Strategy, which is located in London, UK. The title of the tender is "Advance Purchase Agreement" and it falls under the goods category, specifically for vaccines (CPV code: 33651600). The procurement method was limited, with an award procedure conducted without prior publication of a call for competition, and the process is currently at the award stage. The contract, signed on 20th September 2021, is related to the procurement of the Covid-19 Adjuvanted Pandemic Vaccine, although contract values and contract end dates remain undisclosed due to commercial sensitivity.

This tender presents significant opportunities for businesses, particularly those in the pharmaceutical or healthcare sectors, capable of developing or supplying vaccines. Companies that can navigate the competitive landscape of vaccine provision and have the technical capability to meet the specifications outlined in this agreement would be well-positioned to engage. The involvement of major suppliers such as Aventis Pharma Ltd and GlaxoSmithKline Biologicals S.A. illustrates the scale and potential impact of this procurement process, encouraging other large-scale suppliers to consider similar engagements in future vaccine-related initiatives.

How relevant is this notice?

Notice Information

Notice Title

Advance Purchase Agreement

Notice Description

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.

Lot Information

Lot 1

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine. Additional information: Contract value is being withheld due to commercial sensitivity (PCR 2015 Reg 50(6)(b) and (c) and FOIA 2000 Section 43). Publication may enable competitors to calculate cost per dose. This will commercially prejudice: (i) the supplier in its negotiations with other national governments; and (ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.

Procurement Information

The award of the contract to Aventis Pharma and GSK is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii). Furthermore, this Advance Purchase Agreement is the execution of the previous Capacity Reservation Agreement (Please see linked notice)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02ee22
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/026293-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
20 Oct 20214 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
20 Sep 20214 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Business Energy and Industrial Strategy
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW1H 0ET
Postcode Area
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
St James's
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
2
Supplier Names

Aventis Pharma Ltd

GlaxoSmithKline Biologicals S.A

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...